These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 1964125
1. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide. Jespersen B, Jensen L, Sørensen SS, Pedersen EB. Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125 [Abstract] [Full Text] [Related]
2. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome. Jespersen B, Sørensen SS, Pedersen EB. Nephrol Dial Transplant; 1991 Dec; 6(6):402-9. PubMed ID: 1652115 [Abstract] [Full Text] [Related]
3. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration. Jespersen B, Danielsen H, Pedersen EB. Nephrol Dial Transplant; 1990 Dec; 5(12):997-1006. PubMed ID: 1965738 [Abstract] [Full Text] [Related]
4. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver. Jespersen B. Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012 [Abstract] [Full Text] [Related]
5. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. Jespersen B, Eiskjaer H, Jensen JD, Mogensen CE, Sørensen SS, Pedersen EB. Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729 [Abstract] [Full Text] [Related]
6. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites. Dussaule JC, Grangé JD, Wolf JP, Lecomte JM, Gros C, Schwartz JC, Bodin F, Ardaillou R. J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706 [Abstract] [Full Text] [Related]
7. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver]. Gerbes AL, Arendt R, Xie Y, Knorr HJ, Riedel A, Paumgartner G. Z Kardiol; 1988 Mar; 77 Suppl 2():99-103. PubMed ID: 2970181 [Abstract] [Full Text] [Related]
9. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide. Tajiri K, Miyakawa H, Izumi N, Marumo F, Sato C. Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659 [Abstract] [Full Text] [Related]
10. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M, Larochelle P. J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796 [Abstract] [Full Text] [Related]
11. Atrial natriuretic peptide in liver cirrhosis with mild ascites. Miyase S, Fujiyama S, Chikazawa H, Sato T. Gastroenterol Jpn; 1990 Jun; 25(3):356-62. PubMed ID: 2162795 [Abstract] [Full Text] [Related]
12. Role of atrial natriuretic factor, cyclic GMP and the renin-aldosterone system in acute volume regulation of healthy human subjects. Gerbes AL, Arendt RM, Gerzer R, Schnizer W, Jüngst D, Paumgartner G, Wernze H. Eur J Clin Invest; 1988 Aug; 18(4):425-9. PubMed ID: 2844547 [Abstract] [Full Text] [Related]
13. Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension. Sørensen SS, Danielsen H, Amdisen A, Pedersen EB. J Hypertens; 1989 Jan; 7(1):21-9. PubMed ID: 2523419 [Abstract] [Full Text] [Related]
14. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM. Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457 [Abstract] [Full Text] [Related]
15. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. La Villa G, Riccardi D, Lazzeri C, Casini Raggi V, Dello Sbarba A, Tosti Guerra C, Fronzaroli C, Foschi M, Laffi G, Gentilini P. Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983 [Abstract] [Full Text] [Related]
16. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Skorecki KL, Leung WM, Campbell P, Warner LC, Wong PY, Bull S, Logan AG, Blendis LM. Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047 [Abstract] [Full Text] [Related]
17. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. Gentile S, Bologna E, Terracina D, Angelico M. Life Sci; 1994 Sep; 54(21):1585-93. PubMed ID: 8196477 [Abstract] [Full Text] [Related]
18. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites. Morali GA, Floras JS, Legault L, Tobe S, Skorecki KL, Blendis LM. Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288 [Abstract] [Full Text] [Related]
19. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion. Fernández-Rodriguez CM, Prieto J, Quiroga J, Zozaya JM, Andrade A, Rodriguez-Ortigosa C. Dig Dis Sci; 1997 Jul; 42(7):1416-20. PubMed ID: 9246039 [Abstract] [Full Text] [Related]
20. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, Cominelli F, Marra F, Gentilini P. Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828 [Abstract] [Full Text] [Related] Page: [Next] [New Search]